What Is Immunocore Holdings plc (IMCR) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Immunocore Holdings plc's intrinsic value is estimated at $13.54, suggesting the stock is overvalued at its current price of $32.49. With 12 out of 12 models flagging downside (-58.3% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: PWERM targets $28.86 (-11.2%), versus Regime Cross at $1.10 (-96.6%). This +85.4% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About IMCR?
12 of 13 models are currently active for IMCR. All 12 active models suggest the stock trades above fair value. The Bayesian DCF estimates IMCR's intrinsic value at $10.28, implying -68.3% downside from the current price. See which stocks rank higher →
How Does IMCR Rank in Biological Products, (No Diagnostic Substances)?
Among 139 Biological Products, (No Diagnostic Substances) stocks, IMCR ranks #7 by Quality of Company score. CirclFi's QOC score of 7.9/10 evaluates 32 fundamental signals. A score of 7.9 indicates above-average quality.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Immunocore Holdings plc operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is IMCR a Value Trap?
CirclFi's Value Trap algorithm assigns IMCR a score of 6/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Immunocore Holdings plc. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Immunocore Holdings plc's fundamental quality profile registers 7.9/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +85.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every IMCR valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across IMCR's 12 active models, average confidence is 33%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad